
Don't want to miss a thing?
Subscribe to get expert insights, in-depth research, and the latest updates from our team.
Max’s recent stories
By Andriy Rovenchak, Max DruchokOct 02, 2024
Healthcare & Life SciencesNVIDIAR&D
Vielversprechende Ergebnisse in der Entwicklung neuer Arzneimittel durch ML
Erfahren Sie, wie fortschrittliche ML-Methoden und Partnerschaften die Wirkstoffentdeckung beschleunigen.
By Max Druchok, Marta Strohush (Pinyazhko)May 25, 2023
Healthcare & Life SciencesR&D
The Tech (R)evolution in Life Sciences
SoftServe empowers companies to go beyond existing barriers to discover solutions—saving time and money.
By Max Druchok, Oleksandr GurbychMar 23, 2020
R&D
Protein-Peptide Docking
Learn more about our end-to-end molecular docking pipeline that combines deep learning and DFT approaches to predict protein-peptide docking.